Therefore, CSJD may regulate targets such as PIK3CA, AKT1, TNF, IL-6, and others through the lipid and atherosclerosis pathway, block the key pathways and molecules of lipid metabolism, and thus achieve the effect of inhibiting dengue virus replication and improving clinical symptoms of patients. This evidence concerns the gene TNF and atherosclerosis.